These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 18385986
21. Nicotine withdrawal in adolescent and adult rats. O'Dell LE, Bruijnzeel AW, Ghozland S, Markou A, Koob GF. Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887 [Abstract] [Full Text] [Related]
22. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Johnson PM, Hollander JA, Kenny PJ. Pharmacol Biochem Behav; 2008 Sep; 90(3):409-15. PubMed ID: 18466962 [Abstract] [Full Text] [Related]
23. Effects of calcium channel antagonists on the motivational effects of nicotine and morphine in conditioned place aversion paradigm. Budzynska B, Polak P, Biala G. Behav Brain Res; 2012 Mar 01; 228(1):144-50. PubMed ID: 22178315 [Abstract] [Full Text] [Related]
24. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Panagis G, Hildebrand BE, Svensson TH, Nomikos GG. Synapse; 2000 Jan 01; 35(1):15-25. PubMed ID: 10579804 [Abstract] [Full Text] [Related]
29. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Ise Y, Narita M, Nagase H, Suzuki T. Psychopharmacology (Berl); 2000 Jul 01; 151(1):49-54. PubMed ID: 10958116 [Abstract] [Full Text] [Related]
31. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal. Jackson A, Papke RL, Damaj MI. Psychopharmacology (Berl); 2018 Jul 01; 235(7):1897-1905. PubMed ID: 29549391 [Abstract] [Full Text] [Related]
32. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats. Yamada H, Bishnoi M, Keijzers KF, van Tuijl IA, Small E, Shah HP, Bauzo RM, Kobeissy FH, Sabarinath SN, Derendorf H, Bruijnzeel AW. Pharmacol Biochem Behav; 2010 Jun 01; 95(4):401-9. PubMed ID: 20211642 [Abstract] [Full Text] [Related]
33. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area. Hildebrand BE, Panagis G, Svensson TH, Nomikos GG. Neuropsychopharmacology; 1999 Oct 01; 21(4):560-74. PubMed ID: 10481840 [Abstract] [Full Text] [Related]
37. Age-dependent differences in nicotine reward and withdrawal in female mice. Kota D, Martin BR, Damaj MI. Psychopharmacology (Berl); 2008 Jun 01; 198(2):201-10. PubMed ID: 18338157 [Abstract] [Full Text] [Related]
38. The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. Jackson KJ, McIntosh JM, Brunzell DH, Sanjakdar SS, Damaj MI. J Pharmacol Exp Ther; 2009 Nov 01; 331(2):547-54. PubMed ID: 19644040 [Abstract] [Full Text] [Related]
39. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. Watkins SS, Stinus L, Koob GF, Markou A. J Pharmacol Exp Ther; 2000 Mar 01; 292(3):1053-64. PubMed ID: 10688623 [Abstract] [Full Text] [Related]
40. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats. Yuan M, Malagon AM, Yasuda D, Belluzzi JD, Leslie FM, Zaveri NT. Behav Brain Res; 2017 Aug 30; 333():251-257. PubMed ID: 28693859 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]